Private Market View

Meiweida Medical

Shanghai, China · Founded 2021 · Privately Held (backing)

Last price · $/share
Implied valuation
Total raised
Last round

Key facts

  • Notable investors include ChuangVest Ventures, Haorong Investment, Ysun Investment.
  • Status: Privately Held (backing).
Free account
See the evidence behind this price
  • ·The complete investor list — 3 names
  • ·Watchlist + deal alerts for Meiweida Medical
  • ·The full record, as it builds
Create free account
No card required

Funding rounds

No rounds on record

No funding rounds for Meiweida Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

About Meiweida Medical

Manufacturer of medical devices intended to support minimally invasive tumor interventions. The company offers innovative instruments such as a disposable coaxial puncture thermal-coagulation needle and a 5.8 GHz microwave ablation system, enabling oncology clinicians and patients safer, more efficient tumor biopsy and ablation treatments with reduced complications.

Sector
Healthcare
HQ
Shanghai, China
Founded
2021
Ownership
Privately Held (backing)
PA Mark — not yet priced

Meiweida Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.

Pro members can request priority coverage with a 48-hour turnaround.

Recorded secondary trades

No prints on record

No secondary trades in Meiweida Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.

Pro members can request priority coverage with a 48-hour turnaround.

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Meiweida Medical in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.